OpenEvidence: Doctors’ AI Search Engine Valued at US$15bn
OpenEvidence Founder and CEO Daniel Nadler is building the medical AI search engine that US doctors used for 18 million clinical consultations in a month
TL;DR
- OpenEvidence, a medical AI search engine, is used by over 40% of registered US physicians.
- The platform experienced significant revenue growth, reaching an estimated $150m annually by the end of 2025 and projected $300m by July 2026.
- Investors reportedly valued the company at $15bn in September 2026, with substantial funding rounds since its founding in 2022.
- OpenEvidence licenses content from major medical publishers like NEJM Group and JAMA Network, and guidelines from organizations like NCCN.
- Major health systems including Sutter Health, Mount Sinai, and Cedars-Sinai are integrating the AI tool into their systems.
- The company's business model relies on advertising revenue from pharmaceutical and medical device companies, with a potential ad-free version in development.